In cancer, TOLLIP has been described to promote hepatocellular carcinoma via the PI3K/AKT pathway [59], and NPHP3 has been shown to regulate cancer cell viability by mediating the primary cilium formation [60]. Here, NPHP3 is linked to hepatocellular carcinoma.